• 977 Citations
  • 16 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kjetil Boye is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Gastrointestinal Stromal Tumors Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Osteopontin Medicine & Life Sciences
Survival Medicine & Life Sciences
Rupture Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 977 Citations
  • 16 h-Index
  • 42 Article
  • 2 Letter
  • 2 Review article
Open Access
Gastrointestinal Stromal Tumors
Rupture
Recurrence
Neoplasms

Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?

Hølmebakk, T., Bjerkehagen, B., Lobmaier, I. V. K., Hompland, I., Stoldt, S. & Boye, K., Jan 1 2019, (Accepted/In press) In : Annals of surgical oncology.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Neoplasms
Rupture
Recurrence
Sarcoma
2 Citations (Scopus)

Pazopanib in relapsed osteosarcoma patients: report on 15 cases

Longhi, A., Paioli, A., Palmerini, E., Cesari, M., Abate, M. E., Setola, E., Spinnato, P., Donati, D., Hompland, I. & Boye, K., Jan 2 2019, In : Acta Oncologica. 58, 1, p. 124-128 5 p.

Research output: Contribution to journalLetter

Osteosarcoma
pazopanib
5 Citations (Scopus)

Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour

Hølmebakk, T., Bjerkehagen, B., Hompland, I., Stoldt, S. & Boye, K., Mar 2019, In : British Journal of Surgery. 106, 4, p. 419-426 8 p.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Rupture
Recurrence
Neoplasms
Residual Neoplasm
16 Citations (Scopus)

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

Stacchiotti, S., Mir, O., Le Cesne, A., Vincenzi, B., Fedenko, A., Maki, R. G., Somaiah, N., Patel, S., Brahmi, M., Blay, J. Y., Boye, K., Sundby Hall, K., Gelderblom, H., Hindi, N., Martin-Broto, J., Kosela, H., Rutkowski, P., Italiano, A., Duffaud, F., Kobayashi, E. & 3 others, Casali, P. G., Provenzano, S. & Kawai, A., Jan 2018, In : Oncologist. 23, 1, p. 62-70 9 p.

Research output: Contribution to journalArticle

trabectedin
Alveolar Soft Part Sarcoma
Sarcoma
Disease-Free Survival
Rare Diseases